Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Infant, Newborn, Diseases, Infant, Premature, Diseases, Lung Injury, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, Ventilator-Induced Lung Injury, bronchopulmonary dysplasia, lung disorder, pregnancy disorder, respiratory system disorder	Active, not recruiting	Phase 1	2025-07-16		NCT04255147

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Canadian Institutes of Health Research (CIHR)	339
Ontario Institute for Regenerative Medicine	3
Ottawa Hospital Research Institute	121
Stem Cell Network	8

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sunnybrook Health Sciences Centre	Toronto	Canada	167
The Ottawa Hospital - General Campus	Gloucester	Canada	1